Long-term voriconazole and skin cancer: is there cause for concern? (Q45247488)

11 December 2017

title

Long-term voriconazole and skin cancer: is there cause for concern? (English)

1 reference

11 December 2017

1 reference

1 reference

1

Cornelius J Clancy

1 reference

11 December 2017

M Hong Nguyen

2

1 reference

11 December 2017

publication date

1 December 2011

1 reference

Current infectious disease reports

11 December 2017

published in

1 reference

11 December 2017

volume

13

1 reference

11 December 2017

issue

6

1 reference

11 December 2017

page(s)

536-543

1 reference

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Voriconazole therapy in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Successful treatment of coccidioidal meningitis with voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Pseudoporphyria as a result of voriconazole use: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

[Voriconazole photosensitivity: 7 cases]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Voriconazole-induced retinoid-like photosensitivity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

The molecular basis of nonmelanoma skin cancer: new understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Inflammatory doses of UV may not be necessary for skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Voriconazole therapeutic drug monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

De novo tumors after liver transplantation: a single-institution experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

[Skin cancer risk after organ transplantation]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report--2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-011-0220-X

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

21 January 2018

1 reference

12 December 2020

Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy

1 reference

12 December 2020

Incidence and clinical course of de-novo malignancies in renal allograft recipients

1 reference

12 December 2020

Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats

1 reference

12 December 2020

Skin cancer in heart transplant recipients: frequency and risk factor analysis

1 reference

12 December 2020

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

1 reference

12 December 2020

Voriconazole-induced pseudoporphyria

1 reference

12 December 2020

Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study

1 reference

12 December 2020

The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study

1 reference

12 December 2020

10.1007/S11908-011-0220-X

Identifiers

DOI

1 reference

11 December 2017

1 reference